|
π
|
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
16 auth.
A. Latiano,
O. Palmieri,
L. Pastorelli,
M. Vecchi,
T. Pizarro,
F. Bossa,
G. Merla,
Bartolomeo Augello,
T. Latiano,
G. Corritore,
...
A. Settesoldi,
M. R. Valvano,
R. D'IncΓ ,
L. Stronati,
V. Annese,
A. Andriulli
|
6 |
2013 |
6
π
|
|
π¬
|
PPARΞ³ in Inflammatory Bowel Disease
V. Annese,
F. Rogai,
A. Settesoldi,
S. Bagnoli
|
6 |
2012 |
6
π¬
|
|
π¬
|
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factors.
C. Papi,
F. FascΓ-Spurio,
F. Rogai,
A. Settesoldi,
G. Margagnoni,
V. Annese
|
5 |
2013 |
5
π¬
|
|
π¦
|
Ustekinumab: moving the target from psoriasis to Crohn's disease
A. Settesoldi,
M. Coppola,
F. Rogai,
V. Annese
|
3 |
2014 |
3
π¦
|
|
π¦
|
Taeniasis: A possible cause of ileal bleeding
A. Settesoldi,
A. Tozzi,
O. Tarantino
|
2 |
2017 |
2
π¦
|
|
π¦
|
P.16.14 LOSS OF EFFICACY AND ADVERSE DRUG REACTIONS DURING INFLIXIMAB THERAPY IN IBD PATIENTS ARE RELATED TO THE APPEARANCE OF ANTI-INFLIXIMAB ANTIBODIES
13 auth.
A. Settesoldi,
M. Giannotta,
S. Genise,
A. Santini,
S. Bagnoli,
M. Milla,
V. Annese,
A. Matucci,
A. Vultaggio,
G. Petroni,
...
S. Pratesi,
F. Nencini,
E. Maggi
|
0 |
2012 |
0
π¦
|
|
π
|
P280 Characteristics and clinical course of IBD in elderly: report from the web-based IG-IBD Registry
10 auth.
A. Redaelli,
A. Settesoldi,
R. Caccaro,
M. Rea,
A. Orlando,
D. Valpiani,
...
G. Riegler,
R. Pica,
R. Montanari,
V. Annese
|
0 |
2013 |
0
π
|
